Table of Contents 1 Kidney (Renal) Fibrosis Market Overview 1.1 Product Overview and Scope of Kidney (Renal) Fibrosis 1.2 Kidney (Renal) Fibrosis Segment by Type 1.2.1 Global Kidney (Renal) Fibrosis Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Angiotensin Converting enzyme (ACE) Inhibitors 1.2.3 Pirfenidone 1.2.4 Renin Inhibitors 1.2.5 Angiotensin II Receptor Blockers (ARBs) 1.2.6 Vasopeptidase Inhibitors 1.3 Kidney (Renal) Fibrosis Segment by Application 1.3.1 Kidney (Renal) Fibrosis Sales Comparison by Application: 2020 VS 2026 1.3.2 Research Center 1.3.3 Hospital 1.3.4 Clinic 1.4 Global Kidney (Renal) Fibrosis Market Size Estimates and Forecasts 1.4.1 Global Kidney (Renal) Fibrosis Revenue 2015-2026 1.4.2 Global Kidney (Renal) Fibrosis Sales 2015-2026 1.4.3 Kidney (Renal) Fibrosis Market Size by Region: 2020 Versus 2026 2 Global Kidney (Renal) Fibrosis Market Competition by Manufacturers 2.1 Global Kidney (Renal) Fibrosis Sales Market Share by Manufacturers (2015-2020) 2.2 Global Kidney (Renal) Fibrosis Revenue Share by Manufacturers (2015-2020) 2.3 Global Kidney (Renal) Fibrosis Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Kidney (Renal) Fibrosis Manufacturing Sites, Area Served, Product Type 2.5 Kidney (Renal) Fibrosis Market Competitive Situation and Trends 2.5.1 Kidney (Renal) Fibrosis Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Kidney (Renal) Fibrosis Players (Opinion Leaders) 3 Kidney (Renal) Fibrosis Retrospective Market Scenario by Region 3.1 Global Kidney (Renal) Fibrosis Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Kidney (Renal) Fibrosis Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Kidney (Renal) Fibrosis Market Facts & Figures by Country 3.3.1 North America Kidney (Renal) Fibrosis Sales by Country 3.3.2 North America Kidney (Renal) Fibrosis Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Kidney (Renal) Fibrosis Market Facts & Figures by Country 3.4.1 Europe Kidney (Renal) Fibrosis Sales by Country 3.4.2 Europe Kidney (Renal) Fibrosis Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Kidney (Renal) Fibrosis Market Facts & Figures by Region 3.5.1 Asia Pacific Kidney (Renal) Fibrosis Sales by Region 3.5.2 Asia Pacific Kidney (Renal) Fibrosis Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Kidney (Renal) Fibrosis Market Facts & Figures by Country 3.6.1 Latin America Kidney (Renal) Fibrosis Sales by Country 3.6.2 Latin America Kidney (Renal) Fibrosis Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Kidney (Renal) Fibrosis Market Facts & Figures by Country 3.7.1 Middle East and Africa Kidney (Renal) Fibrosis Sales by Country 3.7.2 Middle East and Africa Kidney (Renal) Fibrosis Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Kidney (Renal) Fibrosis Historic Market Analysis by Type 4.1 Global Kidney (Renal) Fibrosis Sales Market Share by Type (2015-2020) 4.2 Global Kidney (Renal) Fibrosis Revenue Market Share by Type (2015-2020) 4.3 Global Kidney (Renal) Fibrosis Price Market Share by Type (2015-2020) 4.4 Global Kidney (Renal) Fibrosis Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Kidney (Renal) Fibrosis Historic Market Analysis by Application 5.1 Global Kidney (Renal) Fibrosis Sales Market Share by Application (2015-2020) 5.2 Global Kidney (Renal) Fibrosis Revenue Market Share by Application (2015-2020) 5.3 Global Kidney (Renal) Fibrosis Price by Application (2015-2020) 6 Company Profiles and Key Figures in Kidney (Renal) Fibrosis Business 6.1 Merck 6.1.1 Corporation Information 6.1.2 Merck Description, Business Overview and Total Revenue 6.1.3 Merck Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Merck Products Offered 6.1.5 Merck Recent Development 6.2 Pfizer 6.2.1 Pfizer Kidney (Renal) Fibrosis Production Sites and Area Served 6.2.2 Pfizer Description, Business Overview and Total Revenue 6.2.3 Pfizer Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Pfizer Products Offered 6.2.5 Pfizer Recent Development 6.3 Roche 6.3.1 Roche Kidney (Renal) Fibrosis Production Sites and Area Served 6.3.2 Roche Description, Business Overview and Total Revenue 6.3.3 Roche Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Roche Products Offered 6.3.5 Roche Recent Development 6.4 InterMune 6.4.1 InterMune Kidney (Renal) Fibrosis Production Sites and Area Served 6.4.2 InterMune Description, Business Overview and Total Revenue 6.4.3 InterMune Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2015-2020) 6.4.4 InterMune Products Offered 6.4.5 InterMune Recent Development 6.5 Galectin Therapeutics 6.5.1 Galectin Therapeutics Kidney (Renal) Fibrosis Production Sites and Area Served 6.5.2 Galectin Therapeutics Description, Business Overview and Total Revenue 6.5.3 Galectin Therapeutics Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Galectin Therapeutics Products Offered 6.5.5 Galectin Therapeutics Recent Development 6.6 La Jolla Pharmaceutical Company 6.6.1 La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Production Sites and Area Served 6.6.2 La Jolla Pharmaceutical Company Description, Business Overview and Total Revenue 6.6.3 La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2015-2020) 6.6.4 La Jolla Pharmaceutical Company Products Offered 6.6.5 La Jolla Pharmaceutical Company Recent Development 6.7 ProMetic Life-Sciences Inc. 6.6.1 ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Production Sites and Area Served 6.6.2 ProMetic Life-Sciences Inc. Description, Business Overview and Total Revenue 6.6.3 ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2015-2020) 6.4.4 ProMetic Life-Sciences Inc. Products Offered 6.7.5 ProMetic Life-Sciences Inc. Recent Development 6.8 BioLine Rx Ltd 6.8.1 BioLine Rx Ltd Kidney (Renal) Fibrosis Production Sites and Area Served 6.8.2 BioLine Rx Ltd Description, Business Overview and Total Revenue 6.8.3 BioLine Rx Ltd Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2015-2020) 6.8.4 BioLine Rx Ltd Products Offered 6.8.5 BioLine Rx Ltd Recent Development 6.9 Genzyme Corporation 6.9.1 Genzyme Corporation Kidney (Renal) Fibrosis Production Sites and Area Served 6.9.2 Genzyme Corporation Description, Business Overview and Total Revenue 6.9.3 Genzyme Corporation Kidney (Renal) Fibrosis Sales, Revenue and Gross Margin (2015-2020) 6.9.4 Genzyme Corporation Products Offered 6.9.5 Genzyme Corporation Recent Development 7 Kidney (Renal) Fibrosis Manufacturing Cost Analysis 7.1 Kidney (Renal) Fibrosis Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Kidney (Renal) Fibrosis 7.4 Kidney (Renal) Fibrosis Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Kidney (Renal) Fibrosis Distributors List 8.3 Kidney (Renal) Fibrosis Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Kidney (Renal) Fibrosis Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Kidney (Renal) Fibrosis by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Kidney (Renal) Fibrosis by Type (2021-2026) 10.2 Kidney (Renal) Fibrosis Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Kidney (Renal) Fibrosis by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Kidney (Renal) Fibrosis by Application (2021-2026) 10.3 Kidney (Renal) Fibrosis Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Kidney (Renal) Fibrosis by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Kidney (Renal) Fibrosis by Region (2021-2026) 10.4 North America Kidney (Renal) Fibrosis Estimates and Projections (2021-2026) 10.5 Europe Kidney (Renal) Fibrosis Estimates and Projections (2021-2026) 10.6 Asia Pacific Kidney (Renal) Fibrosis Estimates and Projections (2021-2026) 10.7 Latin America Kidney (Renal) Fibrosis Estimates and Projections (2021-2026) 10.8 Middle East and Africa Kidney (Renal) Fibrosis Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Kidney (Renal) Fibrosis Sales (MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global Kidney (Renal) Fibrosis Sales (MT) Comparison by Application: 2020 VS 2026 Table 3. Global Kidney (Renal) Fibrosis Market Size by Type (MT) (US$ Million) (2020 VS 2026) Table 4. Global Key Kidney (Renal) Fibrosis Manufacturers Covered in This Study Table 5. Global Kidney (Renal) Fibrosis Sales (MT) by Manufacturers (2015-2020) Table 6. Global Kidney (Renal) Fibrosis Sales Share by Manufacturers (2015-2020) Table 7. Global Kidney (Renal) Fibrosis Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Kidney (Renal) Fibrosis Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Kidney (Renal) Fibrosis Average Price (USD/Kg) of Key Manufacturers (2015-2020) Table 10. Manufacturers Kidney (Renal) Fibrosis Sales Sites and Area Served Table 11. Manufacturers Kidney (Renal) Fibrosis Product Types Table 12. Global Kidney (Renal) Fibrosis Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Kidney (Renal) Fibrosis by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Kidney (Renal) Fibrosis as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Kidney (Renal) Fibrosis Players Table 16. Global Kidney (Renal) Fibrosis Sales (MT) by Region (2015-2020) Table 17. Global Kidney (Renal) Fibrosis Sales Market Share by Region (2015-2020) Table 18. Global Kidney (Renal) Fibrosis Revenue (Million US$) by Region (2015-2020) Table 19. Global Kidney (Renal) Fibrosis Revenue Market Share by Region (2015-2020) Table 20. North America Kidney (Renal) Fibrosis Sales by Country (2015-2020) (MT) Table 21. North America Kidney (Renal) Fibrosis Sales Market Share by Country (2015-2020) Table 22. North America Kidney (Renal) Fibrosis Revenue by Country (2015-2020) (US$ Million) Table 23. North America Kidney (Renal) Fibrosis Revenue Market Share by Country (2015-2020) Table 24. Europe Kidney (Renal) Fibrosis Sales by Country (2015-2020) (MT) Table 25. Europe Kidney (Renal) Fibrosis Sales Market Share by Country (2015-2020) Table 26. Europe Kidney (Renal) Fibrosis Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Kidney (Renal) Fibrosis Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Kidney (Renal) Fibrosis Sales by Region (2015-2020) (MT) Table 29. Asia Pacific Kidney (Renal) Fibrosis Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Kidney (Renal) Fibrosis Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Kidney (Renal) Fibrosis Revenue Market Share by Region (2015-2020) Table 32. Latin America Kidney (Renal) Fibrosis Sales by Country (2015-2020) (MT) Table 33. Latin America Kidney (Renal) Fibrosis Sales Market Share by Country (2015-2020) Table 34. Latin America Kidney (Renal) Fibrosis Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Kidney (Renal) Fibrosis Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Kidney (Renal) Fibrosis Sales by Country (2015-2020) (MT) Table 37. Middle East and Africa Kidney (Renal) Fibrosis Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Kidney (Renal) Fibrosis Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Kidney (Renal) Fibrosis Revenue Market Share by Country (2015-2020) Table 40. Global Kidney (Renal) Fibrosis Sales (MT) by Type (2015-2020) Table 41. Global Kidney (Renal) Fibrosis Sales Share by Type (2015-2020) Table 42. Global Kidney (Renal) Fibrosis Revenue (Million US$) by Type (2015-2020) Table 43. Global Kidney (Renal) Fibrosis Revenue Share by Type (2015-2020) Table 44. Global Kidney (Renal) Fibrosis Price (USD/Kg) by Type (2015-2020) Table 45. Global Kidney (Renal) Fibrosis Sales (MT) by Application (2015-2020) Table 46. Global Kidney (Renal) Fibrosis Sales Market Share by Application (2015-2020) Table 47. Global Kidney (Renal) Fibrosis Sales Growth Rate by Application (2015-2020) Table 48. Merck Kidney (Renal) Fibrosis Corporation Information Table 49. Merck Description and Business Overview Table 50. Merck Kidney (Renal) Fibrosis Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 51. Merck Main Product Table 52. Merck Recent Development Table 53. Pfizer Kidney (Renal) Fibrosis Corporation Information Table 54. Pfizer Corporation Information Table 55. Pfizer Kidney (Renal) Fibrosis Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 56. Pfizer Main Product Table 57. Pfizer Recent Development Table 58. Roche Kidney (Renal) Fibrosis Corporation Information Table 59. Roche Corporation Information Table 60. Roche Kidney (Renal) Fibrosis Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 61. Roche Main Product Table 62. Roche Recent Development Table 63. InterMune Kidney (Renal) Fibrosis Corporation Information Table 64. InterMune Corporation Information Table 65. InterMune Kidney (Renal) Fibrosis Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 66. InterMune Main Product Table 67. InterMune Recent Development Table 68. Galectin Therapeutics Kidney (Renal) Fibrosis Corporation Information Table 69. Galectin Therapeutics Corporation Information Table 70. Galectin Therapeutics Kidney (Renal) Fibrosis Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 71. Galectin Therapeutics Main Product Table 72. Galectin Therapeutics Recent Development Table 73. La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Corporation Information Table 74. La Jolla Pharmaceutical Company Corporation Information Table 75. La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 76. La Jolla Pharmaceutical Company Main Product Table 77. La Jolla Pharmaceutical Company Recent Development Table 78. ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Corporation Information Table 79. ProMetic Life-Sciences Inc. Corporation Information Table 80. ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 81. ProMetic Life-Sciences Inc. Main Product Table 82. ProMetic Life-Sciences Inc. Recent Development Table 83. BioLine Rx Ltd Kidney (Renal) Fibrosis Corporation Information Table 84. BioLine Rx Ltd Corporation Information Table 85. BioLine Rx Ltd Kidney (Renal) Fibrosis Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 86. BioLine Rx Ltd Main Product Table 87. BioLine Rx Ltd Recent Development Table 88. Genzyme Corporation Kidney (Renal) Fibrosis Corporation Information Table 89. Genzyme Corporation Corporation Information Table 90. Genzyme Corporation Kidney (Renal) Fibrosis Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2015-2020) Table 91. Genzyme Corporation Main Product Table 92. Genzyme Corporation Recent Development Table 93. Sales Base and Market Concentration Rate of Raw Material Table 94. Key Suppliers of Raw Materials Table 95. Kidney (Renal) Fibrosis Distributors List Table 96. Kidney (Renal) Fibrosis Customers List Table 97. Market Key Trends Table 98. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 99. Key Challenges Table 100. Global Kidney (Renal) Fibrosis Sales (MT) Forecast by Type (2021-2026) Table 101. Global Kidney (Renal) Fibrosis Sales Market Share Forecast by Type (2021-2026) Table 102. Global Kidney (Renal) Fibrosis Revenue (Million US$) Forecast by Type (2021-2026) Table 103. Global Kidney (Renal) Fibrosis Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 104. Global Kidney (Renal) Fibrosis Sales (MT) Forecast by Application (2021-2026) Table 105. Global Kidney (Renal) Fibrosis Revenue (Million US$) Forecast by Application (2021-2026) Table 106. Global Kidney (Renal) Fibrosis Sales (MT) Forecast by Region (2021-2026) Table 107. Global Kidney (Renal) Fibrosis Sales Market Share Forecast by Region (2021-2026) Table 108. Global Kidney (Renal) Fibrosis Revenue Forecast by Region (2021-2026) (US$ Million) Table 109. Global Kidney (Renal) Fibrosis Revenue Market Share Forecast by Region (2021-2026) Table 110. Research Programs/Design for This Report Table 111. Key Data Information from Secondary Sources Table 112. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Kidney (Renal) Fibrosis Figure 2. Global Kidney (Renal) Fibrosis Sales Market Share by Type: 2020 VS 2026 Figure 3. Angiotensin Converting enzyme (ACE) Inhibitors Product Picture Figure 4. Pirfenidone Product Picture Figure 5. Renin Inhibitors Product Picture Figure 6. Angiotensin II Receptor Blockers (ARBs) Product Picture Figure 7. Vasopeptidase Inhibitors Product Picture Figure 8. Global Kidney (Renal) Fibrosis Consumption Market Share by Application: 2020 VS 2026 Figure 9. Research Center Figure 10. Hospital Figure 11. Clinic Figure 12. Global Kidney (Renal) Fibrosis Market Size 2015-2026 (US$ Million) Figure 13. Global Kidney (Renal) Fibrosis Sales Capacity (MT) (2015-2026) Figure 14. Global Kidney (Renal) Fibrosis Market Size Market Share by Region: 2020 Versus 2026 Figure 15. Kidney (Renal) Fibrosis Sales Share by Manufacturers in 2020 Figure 16. Global Kidney (Renal) Fibrosis Revenue Share by Manufacturers in 2019 Figure 17. The Global 5 and 10 Largest Players: Market Share by Kidney (Renal) Fibrosis Revenue in 2019 Figure 18. Kidney (Renal) Fibrosis Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 19. Global Kidney (Renal) Fibrosis Sales Market Share by Region (2015-2020) Figure 20. Global Kidney (Renal) Fibrosis Sales Market Share by Region in 2019 Figure 21. Global Kidney (Renal) Fibrosis Revenue Market Share by Region (2015-2020) Figure 22. Global Kidney (Renal) Fibrosis Revenue Market Share by Region in 2019 Figure 23. North America Kidney (Renal) Fibrosis Sales Market Share by Country in 2019 Figure 24. North America Kidney (Renal) Fibrosis Revenue Market Share by Country in 2019 Figure 25. U.S. Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 26. U.S. Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 27. Canada Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 28. Canada Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 29. Europe Kidney (Renal) Fibrosis Sales Market Share by Country in 2019 Figure 30. Europe Kidney (Renal) Fibrosis Revenue Market Share by Country in 2019 Figure 31. Germany Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 32. Germany Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 33. France Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 34. France Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 35. U.K. Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 36. U.K. Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 37. Italy Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 38. Italy Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 39. Russia Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 40. Russia Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 41. Asia Pacific Kidney (Renal) Fibrosis Sales Market Share by Region in 2019 Figure 42. Asia Pacific Kidney (Renal) Fibrosis Revenue Market Share by Region in 2019 Figure 43. China Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 44. China Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 45. Japan Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 46. Japan Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 47. South Korea Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 48. South Korea Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 49. India Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 50. India Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 51. Australia Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 52. Australia Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 53. Taiwan Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 54. Taiwan Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 55. Indonesia Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 56. Indonesia Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 57. Thailand Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 58. Thailand Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 59. Malaysia Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 60. Malaysia Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 61. Philippines Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 62. Philippines Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 63. Vietnam Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 64. Vietnam Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 65. Latin America Kidney (Renal) Fibrosis Sales Market Share by Country in 2019 Figure 66. Latin America Kidney (Renal) Fibrosis Revenue Market Share by Country in 2019 Figure 67. Mexico Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 68. Mexico Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 69. Brazil Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 70. Brazil Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 71. Argentina Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 72. Argentina Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 73. Middle East and Africa Kidney (Renal) Fibrosis Sales Market Share by Country in 2019 Figure 74. Middle East and Africa Kidney (Renal) Fibrosis Revenue Market Share by Country in 2019 Figure 75. Turkey Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 76. Turkey Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 77. Saudi Arabia Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 78. Saudi Arabia Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 79. U.A.E Kidney (Renal) Fibrosis Sales Growth Rate (2015-2020) (MT) Figure 80. U.A.E Kidney (Renal) Fibrosis Revenue Growth Rate (2015-2020) (US$ Million) Figure 81. Sales Market Share of Kidney (Renal) Fibrosis by Type (2015-2020) Figure 82. Sales Market Share of Kidney (Renal) Fibrosis by Type in 2019 Figure 83. Revenue Share of Kidney (Renal) Fibrosis by Type (2015-2020) Figure 84. Revenue Market Share of Kidney (Renal) Fibrosis by Type in 2019 Figure 85. Global Kidney (Renal) Fibrosis Sales Growth by Type (2015-2020) (MT) Figure 86. Global Kidney (Renal) Fibrosis Sales Market Share by Application (2015-2020) Figure 87. Global Kidney (Renal) Fibrosis Sales Market Share by Application in 2019 Figure 88. Global Revenue Share of Kidney (Renal) Fibrosis by Application (2015-2020) Figure 89. Global Revenue Share of Kidney (Renal) Fibrosis by Application in 2020 Figure 90. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. InterMune Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Galectin Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. La Jolla Pharmaceutical Company Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. ProMetic Life-Sciences Inc. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. BioLine Rx Ltd Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Genzyme Corporation Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Price Trend of Key Raw Materials Figure 100. Manufacturing Cost Structure of Kidney (Renal) Fibrosis Figure 101. Manufacturing Process Analysis of Kidney (Renal) Fibrosis Figure 102. Kidney (Renal) Fibrosis Industrial Chain Analysis Figure 103. Channels of Distribution Figure 104. Distributors Profiles Figure 105. Porter's Five Forces Analysis Figure 106. North America Kidney (Renal) Fibrosis Sales (MT) and Growth Rate Forecast (2021-2026) Figure 107. North America Kidney (Renal) Fibrosis Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 108. Europe Kidney (Renal) Fibrosis Sales (MT) and Growth Rate Forecast (2021-2026) Figure 109. Europe Kidney (Renal) Fibrosis Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 110. Latin America Kidney (Renal) Fibrosis Sales (MT) and Growth Rate Forecast (2021-2026) Figure 111. Latin America Kidney (Renal) Fibrosis Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 112. Middle East and Africa Kidney (Renal) Fibrosis Sales (MT) and Growth Rate Forecast (2021-2026) Figure 113. Middle East and Africa Kidney (Renal) Fibrosis Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 114. Asia Pacific Kidney (Renal) Fibrosis Sales (MT) and Growth Rate Forecast (2021-2026) Figure 115. Asia Pacific Kidney (Renal) Fibrosis Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 116. Bottom-up and Top-down Approaches for This Report Figure 117. Data Triangulation Figure 118. Key Executives Interviewed

Merck Pfizer Roche InterMune Galectin Therapeutics La Jolla Pharmaceutical Company ProMetic Life-Sciences Inc. BioLine Rx Ltd Genzyme Corporation